NAS:RARX (USA) Also Trade In: Germany
Ra Pharmaceuticals Inc $ 47.99 0 (0%)
Warning! GuruFocus has detected 2 Severe warning signs with RARX. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for RARX (Ra Pharmaceuticals Inc) from 2016 to Oct 27 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Ra Pharmaceuticals stock (RARX) PE ratio as of Oct 27 2020 is 0. More Details
Ra Pharmaceuticals PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Ra Pharmaceuticals PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:INO NAS:PRNB NAS:TPTX NAS:KRTX NAS:TGTX NAS:ALEC NYSE:ADCT NAS:ICPT NAS:SAGE NAS:APLS OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 87 Cambridge Park Drive, Cambridge, MA, USA, 02140
Ra Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers and develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Geographically business of the firm can be seen amplifying in the United States, Europe and even at international level.